3-129466891-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_052989.3(IFT122):c.565C>T(p.Arg189*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R189R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_052989.3 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- cranioectodermal dysplasia 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- cranioectodermal dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_052989.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IFT122 | NM_052989.3 | MANE Select | c.565C>T | p.Arg189* | stop_gained splice_region | Exon 8 of 30 | NP_443715.1 | ||
| IFT122 | NM_052985.4 | c.718C>T | p.Arg240* | stop_gained splice_region | Exon 9 of 31 | NP_443711.2 | |||
| IFT122 | NM_001410808.1 | c.565C>T | p.Arg189* | stop_gained splice_region | Exon 8 of 30 | NP_001397737.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IFT122 | ENST00000348417.7 | TSL:1 MANE Select | c.565C>T | p.Arg189* | stop_gained splice_region | Exon 8 of 30 | ENSP00000324005.4 | ||
| IFT122 | ENST00000296266.7 | TSL:1 | c.718C>T | p.Arg240* | stop_gained splice_region | Exon 9 of 31 | ENSP00000296266.3 | ||
| IFT122 | ENST00000507564.5 | TSL:1 | c.716+2110C>T | intron | N/A | ENSP00000425536.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251482 AF XY: 0.0000441 show subpopulations
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461332Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 727032 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cranioectodermal dysplasia 1 Pathogenic:3
This sequence change creates a premature translational stop signal (p.Arg240*) in the IFT122 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT122 are known to be pathogenic (PMID: 20493458, 23826986, 26792575). This variant is present in population databases (rs138329739, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with IFT122-related conditions. ClinVar contains an entry for this variant (Variation ID: 581786). For these reasons, this variant has been classified as Pathogenic.
Variant summary: IFT122 c.718C>T (p.Arg240X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, a commonly known mechanism for disease. The variant allele was found at a frequency of 5.2e-05 in 251482 control chromosomes (gnomAD). To our knowledge, no occurrence of c.718C>T in individuals affected with Cranioectodermal Dysplasia 1 and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic.
IFT122-related disorder Pathogenic:1
The IFT122 c.718C>T variant is predicted to result in premature protein termination (p.Arg240*). This variant has not been reported in an individual with IFT122 related disease. This variant is reported in 0.028% of alleles in individuals of African descent in gnomAD. Nonsense variants in IFT122 are expected to be pathogenic. This variant is interpreted as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at